Medical technology company Semler Scientific has disclosed plans for a potential $500 million funding round through SEC filings. The company is seeking approval to issue various securities, including stocks, bonds, or other financial instruments, in future offerings. Specific issuance details will be provided as they are released. Semler also indicated that these securities could be offered via direct offerings or through intermediaries like brokers and underwriters. 2024 has seen significant price fluctuations for the company’s stock, trading between $21.03 and $74.73, settling most recently at $34.26. Volatility is linked to broader crypto market shifts and Semler’s recent adoption of Bitcoin as part of its treasury reserves. Despite these swings, Semler maintains that its core business and financial stability remain unaffected. The company entered the Bitcoin space last year, joining a growing number of public companies that are allocating capital to digital assets.